Company intelligence / Profile preview

Reaction Biology

Malvern, Pennsylvania, United Statesreactionbiology.com ↗

Ownership: Private
Development stage: Other

Overview

Reaction Biology is not itself developing therapeutics but provides preclinical drug discovery services such as target validation, hit identification/optimization, compound screening/profiling—including cell-based and in vivo oncology models—to biopharma clients worldwide. They do not have their own clinical results or pipeline; rather they enable client programs at the preclinical stage[1][3][5].

Therapeutic areas: OncologyOther
Modalities: Small moleculeProteinPeptidesAntibodies
Industry: Drug Discovery Services

Partnerships

University of California San FranciscoEvotec Compound ManagementSRI InternationalSanford Burnham Prebys Medical Discovery InstituteThe Scripps Research Institute

Beyond the preview

Go deeper on Reaction Biology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reaction Biology.

Explore the full profile